| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.YMGME.2011.09.021 |
| P698 | PubMed publication ID | 22000754 |
| P50 | author | José M Fraga | Q57686568 |
| José Ramón Alonso-Fernández | Q58803416 | ||
| María L Couce | Q64175929 | ||
| Cristóbal Colón | Q64532843 | ||
| P2093 | author name string | Daisy E Castiñeiras | |
| José A Cocho | |||
| Ma Dolores Bóveda | |||
| Ana Baña | |||
| Agustín J Iglesias | |||
| P2860 | cites work | Newborn screening: toward a uniform screening panel and system--executive summary | Q28242948 |
| Clinical, biochemical, and molecular spectrum of hyperargininemia due to arginase I deficiency | Q33737998 | ||
| The National Austrian Newborn Screening Program – Eight years experience with mass spectrometry. Past, present, and future goals | Q34142989 | ||
| Expanded newborn screening for inborn errors of metabolism by electrospray ionization-tandem mass spectrometry: results, outcome, and implications | Q34201641 | ||
| Use of tandem mass spectrometry for multianalyte screening of dried blood specimens from newborns | Q34272296 | ||
| Short-chain acyl-CoA dehydrogenase (SCAD) deficiency: an examination of the medical and neurodevelopmental characteristics of 14 cases identified through newborn screening or clinical symptoms | Q34378278 | ||
| 'Classical' organic acidurias, propionic aciduria, methylmalonic aciduria and isovaleric aciduria: long-term outcome and effects of expanded newborn screening using tandem mass spectrometry. | Q34536489 | ||
| Arguments for early screening: a clinician's perspective | Q40546757 | ||
| Vertical sandwich-type continuous/evaporative TLC with fixed mobile phase volume for separating sugars of clinical relevance in paper-borne urine and blood samples in newborn screening. | Q43120217 | ||
| Tandem mass spectrometry: a new method for acylcarnitine profiling with potential for neonatal screening for inborn errors of metabolism | Q43990199 | ||
| Screening newborns for inborn errors of metabolism by tandem mass spectrometry | Q44467193 | ||
| Frequencies of inherited organic acidurias and disorders of mitochondrial fatty acid transport and oxidation in Germany | Q44721348 | ||
| Four years of expanded newborn screening in Portugal with tandem mass spectrometry | Q44761087 | ||
| Worldwide survey of neonatal screening for biotinidase deficiency | Q44932007 | ||
| The urinary excretion of glutarylcarnitine is an informative tool in the biochemical diagnosis of glutaric acidemia type I. | Q45238245 | ||
| Glutaric aciduria type I: outcome following detection by newborn screening | Q46443662 | ||
| Hypermethioninaemia due to methionine adenosyltransferase I/III (MAT I/III) deficiency: diagnosis in an expanded neonatal screening programme. | Q46578215 | ||
| Neonatal screening for medium-chain acyl-CoA dehydrogenase (MCAD) deficiency in The Netherlands: the importance of enzyme analysis to ascertain true MCAD deficiency. | Q46813109 | ||
| Management and outcome in 75 individuals with long-chain fatty acid oxidation defects: results from a workshop | Q47927249 | ||
| Maple syrup urine disease: favourable effect of early diagnosis by newborn screening on the neonatal course of the disease | Q48480653 | ||
| Projected costs, risks, and benefits of expanded newborn screening for MCADD. | Q48894362 | ||
| Expanded newborn screening: outcome in screened and unscreened patients at age 6 years. | Q51819165 | ||
| Clinical validation of cutoff target ranges in newborn screening of metabolic disorders by tandem mass spectrometry: a worldwide collaborative project. | Q53438013 | ||
| Outcome of neonatal screening for medium-chain acyl-CoA dehydrogenase deficiency in Australia: a cohort study. | Q55042915 | ||
| Continuous thin-layer chromatography of sugars of clinical interest in samples of urine impregnated on paper | Q71044419 | ||
| 3-Methylcrotonyl-CoA carboxylase deficiency: metabolic decompensation in a noncompliant child detected through newborn screening | Q79400906 | ||
| Guideline for the diagnosis and management of glutaryl-CoA dehydrogenase deficiency (glutaric aciduria type I) | Q79489164 | ||
| Expanded newborn screening in Europe 2007 | Q80647944 | ||
| The tandem mass spectrometry newborn screening experience in North Carolina: 1997-2005 | Q83120524 | ||
| Inborn errors of metabolism in a neonatology unit: impact and long-term results | Q84296815 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 470-475 | |
| P577 | publication date | 2011-09-22 | |
| P1433 | published in | Molecular Genetics and Metabolism | Q6895949 |
| P1476 | title | Evaluation and long-term follow-up of infants with inborn errors of metabolism identified in an expanded screening programme | |
| P478 | volume | 104 |
| Q56590921 | Acute care utilization for inherited metabolic diseases among children identified through newborn screening in New York state |
| Q38325924 | An audit of newborn screening procedure: impact on infants presenting clinically before results are available |
| Q38817983 | Appropriateness of newborn screening for classic galactosaemia: a systematic review. |
| Q87421369 | Biochemical and molecular characteristics of patients with organic acidaemias and urea cycle disorders identified through newborn screening |
| Q44528675 | Biochemical screening of 504,049 newborns in Denmark, the Faroe Islands and Greenland--experience and development of a routine program for expanded newborn screening. |
| Q57793086 | Dietary Management of Propionic Acidemia: Parent Caregiver Perspectives and Practices |
| Q45715465 | Differences between acylcarnitine profiles in plasma and bloodspots |
| Q48692302 | Expanded newborn screening in New South Wales: missed cases |
| Q46152889 | Follow-up status during the first 5 years of life for metabolic disorders on the federal Recommended Uniform Screening Panel |
| Q40282534 | Glutaric acidemia type 1: outcomes before and after expanded newborn screening |
| Q64044271 | Incidence of maple syrup urine disease, propionic acidemia, and methylmalonic aciduria from newborn screening data |
| Q91403090 | Liver transplantation in propionic and methylmalonic acidemia: A single center study with literature review |
| Q92017156 | Methylmalonic and propionic acidemia among hospitalized pediatric patients: a nationwide report |
| Q37716686 | Newborn Screening Programmes in Europe, Arguments and Efforts Regarding Harmonisation: Focus on Organic Acidurias |
| Q39033516 | Nine years of newborn screening for classical galactosemia in the Netherlands: Effectiveness of screening methods, and identification of patients with previously unreported phenotypes |
| Q26865440 | Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia |
| Q47116026 | Reference values of amino acids, acylcarnitines and succinylacetone by tandem mass spectrometry for use in newborn screening in southwest Colombia. |
| Q87813711 | Spectrum analysis of common inherited metabolic diseases in Chinese patients screened and diagnosed by tandem mass spectrometry |
| Q64089892 | Systematic literature review and meta-analysis on the epidemiology of methylmalonic acidemia (MMA) with a focus on MMA caused by methylmalonyl-CoA mutase (mut) deficiency |
| Q64040573 | Systematic literature review and meta-analysis on the epidemiology of propionic acidemia |
Search more.